Literature DB >> 15516473

Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease.

L M Seccombe1, P T Kelly, C K Wong, P G Rogers, S Lim, M J Peters.   

Abstract

BACKGROUND: Commercial aircraft cabins provide a hostile environment for patients with underlying respiratory disease. Although there are algorithms and guidelines for predicting in-flight hypoxaemia, these relate to chronic obstructive pulmonary disease (COPD) and data for interstitial lung disease (ILD) are lacking. The purpose of this study was to evaluate the effect of simulated cabin altitude on subjects with ILD at rest and during a limited walking task.
METHODS: Fifteen subjects with ILD and 10 subjects with COPD were recruited. All subjects had resting arterial oxygen pressure (PaO2) of >9.3 kPa. Subjects breathed a hypoxic gas mixture containing 15% oxygen with balance nitrogen for 20 minutes at rest followed by a 50 metre walking task. Pulse oximetry (SpO2) was monitored continuously with testing terminated if levels fell below 80%. Arterial blood gas tensions were taken on room air at rest and after the resting and exercise phases of breathing the gas mixture.
RESULTS: In both groups there was a statistically significant decrease in arterial oxygen saturation (SaO2) and PaO2 from room air to 15% oxygen at rest and from 15% oxygen at rest to the completion of the walking task. The ILD group differed significantly from the COPD group in resting 15% oxygen SaO2, PaO2, and room air pH. Means for both groups fell below recommended levels at both resting and when walking on 15% oxygen.
CONCLUSION: Even in the presence of acceptable arterial blood gas tensions at sea level, subjects with both ILD and COPD fall below recommended levels of oxygenation when cabin altitude is simulated. This is exacerbated by minimal exercise. Resting sea level arterial blood gas tensions are similarly poor in both COPD and ILD for predicting the response to simulated cabin altitude.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516473      PMCID: PMC1746875          DOI: 10.1136/thx.2004.022210

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

Review 2.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

3.  Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude.

Authors:  C C Christensen; M Ryg; O K Refvem; O H Skjønsberg
Journal:  Eur Respir J       Date:  2000-04       Impact factor: 16.671

4.  Oxygen supplementation during air travel in patients with chronic obstructive lung disease.

Authors:  B W Berg; T A Dillard; K R Rajagopal; W J Mehm
Journal:  Chest       Date:  1992-03       Impact factor: 9.410

5.  Recommendations for patients with chronic respiratory disease considering air travel: a statement from the Canadian Thoracic Society.

Authors:  D Lien; M Turner
Journal:  Can Respir J       Date:  1998 Mar-Apr       Impact factor: 2.409

6.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

7.  Is normobaric simulation of hypobaric hypoxia accurate in chronic airflow limitation?

Authors:  M T Naughton; P D Rochford; J J Pretto; R J Pierce; N F Cain; L B Irving
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

8.  Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction.

Authors:  H Gong; D P Tashkin; E Y Lee; M S Simmons
Journal:  Am Rev Respir Dis       Date:  1984-12

9.  Lung function during moderate hypobaric hypoxia in normal subjects and patients with chronic obstructive pulmonary disease.

Authors:  T A Dillard; K R Rajagopal; W A Slivka; B W Berg; W J Mehm; N P Lawless
Journal:  Aviat Space Environ Med       Date:  1998-10

10.  Effect of hypobaric hypoxia on blood gases in patients with restrictive lung disease.

Authors:  C C Christensen; M S Ryg; O Kåre Refvem; O Henning Skjønsberg
Journal:  Eur Respir J       Date:  2002-08       Impact factor: 16.671

View more
  11 in total

Review 1.  Oxygen and inhalers.

Authors:  Graeme P Currie; J Graham Douglas
Journal:  BMJ       Date:  2006-07-01

2.  A chronic pneumothorax and fitness to fly.

Authors:  Graeme P Currie; Ann-Maree Kennedy; Edward Paterson; Stephen J Watt
Journal:  Thorax       Date:  2007-02       Impact factor: 9.139

3.  Lung disease at high altitude.

Authors:  Joshua O Stream; Andrew M Luks; Colin K Grissom
Journal:  Expert Rev Respir Med       Date:  2009-12       Impact factor: 3.772

4.  Air travel in women with lymphangioleiomyomatosis.

Authors:  Stacey Pollock-BarZiv; Marsha M Cohen; Gregory P Downey; Simon R Johnson; Eugene Sullivan; Francis X McCormack
Journal:  Thorax       Date:  2006-10-13       Impact factor: 9.139

5.  Proof of Concept Study to Assess the Influence of Oxygen Partial Pressure in Capillary Blood on SMBG Measurements.

Authors:  Annette Baumstark; Stefan Pleus; Nina Jendrike; Christina Liebing; Rolf Hinzmann; Cornelia Haug; Guido Freckmann
Journal:  J Diabetes Sci Technol       Date:  2019-03-06

6.  Effects of commercial air travel on patients with pulmonary hypertension air travel and pulmonary hypertension.

Authors:  Nareg Roubinian; C Gregory Elliott; Christopher F Barnett; Paul D Blanc; Joan Chen; Teresa De Marco; Hubert Chen
Journal:  Chest       Date:  2012-10       Impact factor: 9.410

Review 7.  [Air travel and respiratory diseases].

Authors:  Francisco García Río; Luis Borderías Clau; Ciro Casanova Macario; Bartolomé R Celli; Joan Escarrabill Sanglás; Nicolás González Mangado; Josep Roca Torrent; Fernando Uresandi Romero
Journal:  Arch Bronconeumol       Date:  2007-02       Impact factor: 4.872

8.  Predicting the need for supplemental oxygen during airline flight in patients with chronic pulmonary disease: a comparison of predictive equations and altitude simulation.

Authors:  Ana C Bradi; Marie E Faughnan; Matthew B Stanbrook; Eva Deschenes-Leek; Kenneth R Chapman
Journal:  Can Respir J       Date:  2009 Jul-Aug       Impact factor: 2.409

9.  Pre-flight evaluation of adult patients with cystic fibrosis: a cross-sectional study.

Authors:  Elisabeth Edvardsen; Aina Akerø; Ole Henning Skjønsberg; Bjørn Skrede
Journal:  BMC Res Notes       Date:  2017-02-06

10.  BTS Clinical Statement on air travel for passengers with respiratory disease.

Authors:  Robina Kate Coker; Alison Armstrong; Alistair Colin Church; Steve Holmes; Jonathan Naylor; Katharine Pike; Peter Saunders; Kristofer John Spurling; Pamela Vaughn
Journal:  Thorax       Date:  2022-02-28       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.